Country Reports

Saudi Arabia is moving fast, thinking big and aiming high as it powers towards the goals set forth in its Vision 2030 national transformation plan. The astonishing pace and extent of change underway throughout the Kingdom is fuelling major progress within the realm of healthcare and life science. The Middle East’s largest country and its…

Mexico’s healthcare and life sciences sector is at a pivotal moment. As a country with deep manufacturing expertise, a rapidly evolving regulatory landscape, and a strategic position at the heart of North America, Mexico is both a regional powerhouse and a critical player in the global healthcare ecosystem. But with opportunity comes challenge, and 2025…

China’s position as one of the top global sources and recipients of biopharmaceutical innovation is inarguable. As the Year of the Dragon draws to a close, leading Chinese life sciences stakeholders remain undimmed in their commitment to the country and the myriad opportunities to bring breakthroughs to patients, both within China’s borders and beyond. Healthcare…

Switzerland stands tall as a global powerhouse in healthcare and life sciences, a nation where innovation and precision converge to shape the future of medicine. With its thriving biotech ecosystem, groundbreaking research, and advanced manufacturing capabilities, Switzerland remains the gold standard in Europe—punching far above its weight for a country of just 8.5 million. Home…

One year on from our last report on the healthcare and life sciences ecosystem in Hong Kong and the Greater Bay Area (GBA), a lot has changed. Major new collaborative infrastructure projects, including the Hong Kong-Shenzhen Innovation and Technology Park and the GBA Clinical Trial Institute, have made significant progress and promise to reshape the…

Under its overarching ‘Vision 2030’ economic diversification plan, Saudi is aiming to play a much greater regional and global role in everything from artificial intelligence to sport and, significantly, healthcare. Ambitious and wide-ranging transformation plans are in place to raise health span and deepen care coverage, while local and female participation in the workforce is…

Rising per capita GDP, enhanced purchasing power, and a surge in inward-bound FDI flows mean that the Indian economy is on its strongest footing in generations. India’s leading industries – notably its life science sector – are reaping the rewards and anticipating rapid market growth. The USD 65 billion Indian pharma market is predicted to…

Healthcare & Life Sciences Review Portugal 2024 – drawing from over 30 interviews with key stakeholders from industry, government, academia, and hospitals – paints a picture of a nation and a sector not without its challenges, but gradually carving out some highly promising niches. Topics covered in this comprehensive and up-to-date new report include deep…

Morocco, and its healthcare sector, have reached a pivotal moment. The North African nation is currently implementing the most ambitious, far-reaching, and comprehensive health system reorganization in its history along with a major shake-up of the regulatory frameworks governing the country’s local pharmaceuticals industry. All of this is occurring within the context of a cross-industry…

Long considered a destination of choice for life science multinationals seeking to tap into the latent potential of Middle Eastern markets, the United Arab Emirates’ pharmaceuticals, medtech and healthcare sectors have all been exhibiting significant growth momentum in the post-pandemic period. This comprehensive new report, based on interviews with government officials, KOLs, representatives of multinational…

Post-COVID and with a national-level strategy in place to bolster its traditional strengths as well as spearhead entry into new sectors, Hong Kong has reason for optimism once again. One of two special administrative regions (SARs) in southern China with separate laws and regulations to the rest of the country, Hong Kong has had to…

It is undeniable that Belgium holds a strong position as a vibrant life sciences hub at the heart of Europe. Although the country itself represents only a mid-sized marketplace, Belgium boasts a robust environment that fosters multinational drug makers as well as home-grown biotechs and is replete with singular expertise. From its strategic position at…